This Article supports SDG 3 by reporting the global incidence and years of life lived with disability for spinal cord injury from 1990 to 2019.
Background: Gender-based disparities in health-care are common and can affect access to care.
This Article supports SDG 3 by estimating burdens of other musculoskeletal disorders (conditions other than osteoarthritis, rheumatoid arthritis, gout, low back pain, and neck pain), which are a source of a large amount of disability globally; they are the sixth leading cause of years lived with disability globally, and the authors note they are an important consideration for policies regarding musculoskeletal health.
This article aligns with Sustainable Development Goal 11: Sustainable Cities and Communities. The research focuses on transitioning the construction industry towards sustainable practices by utilizing local biological materials and developing a construction method for tension-compression anticlastic shellular structures. The use of a fully biodegradable material system and an earthen construction workflow helps minimize the environmental footprint in the built environment.
This article aligns with Sustainable Development Goal 3: Good Health and Well-being. The use of polymer-functionalized plant leaf scaffolds as a novel human cell culture platform for tissue engineering applications, specifically for promoting the alignment and elongation of muscle cells, contributes to advancements in healthcare and the development of functional skeletal muscle tissue.
This paper concludes that it is imperative to identify effective, early treatments for Alzheimer's disease. Creatine is an important bioenergetic molecule, and the Creatine system is shown to be dysfunctional in the brain of individuals with Alzheimer's disease. Therefore, Ceatine may serve as a potential target for prevention and therapy and creatine monohydrate supplementation may be beneficial in Alzheimer's disease. To date, only rodent studies have investigated the use of creatine monohydrate as a treatment for Alzheimer's disease.. Thus, clinical trials investigating the effects of creatine monohydrateon cognition and creatine monohydrate’s mechanisms in humans with Alzheimer's disease as well as its potential as a strategy to prevent cognitive decline in those with normal cognition, are needed. There is much to be learned about CrM intervention and brain health in different life and disease phases.
This study highlights that pomegranate supplementation can be a promising source of protection against Alzheimer's disease.
The “contour smoothing” fractal analysis method can effectively examine cerebral hemispheres to detect and quantify age-related atrophic changes associated with normal or pathological aging. This method holds promise for clinical application in diagnosing neurodegenerative disorders, such as Alzheimer’s disease.
This study finds that pine nut peptide-zinc chelate improves Alzheimer's Disease (AD) in various ways which include (1) improving learning, memory, brain health, and gut balance in mice, and (2) treating cholinergic system changes, boosting cerebral antioxidants, and altering gut microbiota. Pine nut peptide-zinc chelate holds potential for AD therapy, requiring deeper mechanistic investigation.
This Series paper supports SDG 3 by evaluating existing and emerging vaccines and vaccination campaigns against hepatitis B virus and other sexually transmitted infections, as well as other interventions such as PrEP for HIV
This article contributes to SDG 3 by developing predictive tools to improve clinical management of autoimmune hepatitis.
